MAPT and Alzheimer disease: Likewise, the study by Chatterjee et al. (2016) shows impaired phospholipid and sphingolipid metabolism in patients with familial forms of AD, linking the presence of these lipids with cerebrospinal fluid amyloid and tau protein [42].